News From The Journal Of Neuroscience
Main Category: Neurology / NeuroscienceAlso Included In: Epilepsy; Genetics; Biology / Biochemistry
Article Date: 10 Oct 2007 - 1:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
5 (1 votes) |
1. Watching the Insertion of AMPA Receptors
Guillermo A. Yudowski, Manojkumar A. Puthenveedu, Dmitri Leonoudakis, Sandip Panicker, Kurt S. Thorn, Eric C. Beattie, and Mark von Zastrow
This week Yudowski et al. give a new definition to "AMPA receptor minis." Instead of monitoring the response of postsynaptic receptors to packets of transmitter release (the usual definition of a "mini"), the authors monitored packets of postsynaptic receptors as they were inserted into the postsynaptic membrane. The authors tagged receptor subunits with a pH-sensitive fluorescent label that was activated when the acidic vesicular interior met the neutral extracellular media. Once in the membrane, AMPA receptors moved at two distinct rates; some dissipated within hundreds of milliseconds, whereas other spots stayed clustered for 5-10 s before drifting apart. Chemical stimulation of release increased insertion. Both the transient and persistent insertion events occurred throughout the length of dendrites but never within dendritic spines. Rather, labeled AMPA receptors appeared to reach nearby spines by lateral diffusion from the transient exocytotic insertions.
2. Fate Mapping Cortical Interneurons
Matthew Fogarty, Matthew Grist, Diego Gelman, Oscar Marín, Vassilis Pachnis, and Nicoletta Kessaris
Cortical interneurons march to their own drummer when it comes to their path to the cortex. In this issue, Fogarty et al. used fate mapping to examine the origin of interneurons from subsets of precursor cells in the subpallial neuroepithelium. Using Cre-lox technology in transgenic mice, the authors took advantage of region-specific expression of homeobox transcription factors. Cells expressing Nkx2.1 in the medial ganglionic eminence (MGE) gave rise to interneurons expressing mainly calbindin, parvalbumin, and somatostatin (SST). Calretinin (CR) and SST-expressing Martinotti cells arose from precursors in the dorsal MGE that expressed Nkx6.2 and Lhx6, as did some neuropeptide Y (NPY) cells. Most CR and NPY interneurons began as precursor cells in the lateral/caudal ganglion eminence (LGE/CGE) that expressed Gsh2. Now if you can remember all those acronyms, you can find the birthplace of your favorite interneuron.
3. The Control of Human Locomotion
Yuri P. Ivanenko, Germana Cappellini, Nadia Dominici, Richard E. Poppele, and Francesco Lacquaniti
This week, Ivanenko et al. looked for universal control elements in different forms of human locomotion. Subjects walked, ran, and hopped over the ground, on a treadmill, even in the air suspended from a harness. Sounds like fun, eh? Video data were collected from infrared markers placed along the body from the pelvis to the foot and from a force plate under the "ground" surface. Subjects were also asked to walk with crouched knees, with knees locked, and to step over an obstacle, in order to isolate kinematic variables. Not surprisingly, walking and running gaits differed fundamentally, even at the same speeds. The walking leg acts as a rigid strut, but during running it compresses like a spring. Hopping contained elements of both gaits. Each gait could be defined by two whole-limb components, namely limb axis length and orientation. The authors contend that to simplify control of locomotion, the brain employs a modular strategy, coordinating whole limbs rather than their individual components.
4. The Many Faces of SCN1A Mutants
Raffaella Rusconi, Paolo Scalmani, Rita Restano Cassulini, Giulia Giunti, Antonio Gambardella, Silvana Franceschetti, Grazia Annesi, Enzo Wanke, and Massimo Mantegazza
Franck Kalume, Frank H. Yu, Ruth E. Westenbroek, Todd Scheuer, and William A. Catterall
Even the same mutation in genes encoding voltage-gated sodium channel subunits can cause different types of seizures, confounding efforts to match a genotype with an epileptic phenotype. Two papers this week make strides towards understanding the mutant genotype of the devastating Severe Myoclonic Epilepsy in Infancy (SMEI) phenotype. Kalume et al. studied a mouse with a loss-of-function mutation in Nav1.1 that mimics SMEI, including severe ataxia. The authors traced the poor coordination, tremor, and hypotonia in these mice to a reduction in excitability of Purkinje neurons. Mice heterozygous for the mutation displayed milder ataxia. Rusconi et al. looked at another Nav1.1 loss-of-function mutation in the C-terminal cytoplasmic domain, M1841T. This mutation causes familial epilepsy with a range of phenotypes. Coexpression of the β1 accessory subunit partially rescued lost sodium currents in cells transfected with this mutant Nav1.1 without altering the functional channel properties. Sodium currents were also temperature sensitive, indicating that the M1841T mutation causes a trafficking defect.
### Please click here for the current table of contents.
Source: Sara Harris
Society for Neuroscience
Visit our neurology / neuroscience section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/85111.php>
APA
http://www.medicalnewstoday.com/releases/85111.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




